Skip to content
Subscriber Only

AstraZeneca Treatments Win Orphan FDA Status in Liver Cancer

AstraZeneca Plc Raises Sales Forecast as New Cancer Treatments Gain
Photographer: Mikael Sjoberg/Bloomberg
Updated on

Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.

Two AstraZeneca Plc cancer drugs received orphan status for treatment of liver cancer, a designation that may eventually speed progress to approval.